Yoshimura, Ryo-ichi https://orcid.org/0000-0001-9435-1503
Toda, Kazuma
Watanabe, Hiroshi
Miura, Masahiko
Notake, Ryoichi
Murakami, Naoya
Igaki, Hiroshi
Nakamura, Satoshi
Umezawa, Rei
Kadoya, Noriyuki
Jingu, Keiichi
Itami, Jun
Funding for this research was provided by:
AlphaTau Medical
HekaBio K.K.
Article History
Received: 25 October 2024
Accepted: 4 February 2025
First Online: 19 February 2025
Declarations
:
: Ryo-ichi Yoshimura served as an advisory role to HekaBio K.K.; Kazuma Toda received a research funding from HekaBio K.K.; Masahiko Miura served as an advisory role to HekaBio K.K.; Naoya Murakami received honoraria from Elekta K.K., Chiyoda Technol, Teleflex, and Bayer Japan, and a research funding from Elekta K.K.; Keiichi Jingu received honoraria from Novartis pharma K.K. and a research funding from Elekta K.K.; Jun Itami received honoraria from HekaBio K.K. and a research funding from Teleflex; Hiroshi Watanabe, Ryoichi Notake, Hiroshi Igaki, Satoshi Nakamura, Rei Umezawa, and Noriyuki Kadoya have no conflict of interest.